In recent news that our pharmacy error injury attorneys in Baltimore, Maryland have been following, CVS Pharmacy will reportedly pay $75 million for breaking the law by selling huge quantities of psuedoephedrine, the key ingredient in the manufacturing of methamphetamine, an illegal drug abused widely in California.
Psuedoephedrine, or PSE is found in specific cold and allergy medications, and necessary to produce methamphetamine, a highly addictive stimulant with links to crime and violence in California, among other states. In an effort to reduce pharmacy error, and production of methamphetamine, the Combat Methamphetamine Epidemic Act of 2005 was introduced, to require retailers who carry PSE products to shelf them behind the counter, to check the identification of the person purchasing the drug, and to limit sales to the individual or one package a day, and three a month. Each customer is also required to sign for the purchase.
According to Thomas Ryan, CVS Caremark Chairman, the sale of the products containing PSE was an illegal and unacceptable violation of CVS’s policies, and inconsistent with the drug chain’s values. The CVS company admitted that drugstores in California and Nevada, among other states, were susceptible for over a year to criminal manufacturers who repeatedly bought enough PSE to make Methamphetamine.
The U.S. Drug Enforcement Administration (DEA) stated that CVS’s violations made the company directly linked to the methamphetamine supply chain, and that the company only reversed the problem once the government investigated the pharmacy violation.